Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

NeuroPace (NPCE) Asset Utilization Ratio (2021 - 2026)

NeuroPace's quarterly Asset Utilization Ratio came in at 0.97 in Q1 2026, up 18.28% year-on-year from 0.82 in Q1 2025, and up 3.61% quarter-over-quarter from 0.94 in Q4 2025.

NeuroPace has reported Asset Utilization Ratio for 6 years, with the latest figure at 0.97 in Q1 2026.

  • For the quarter ending Q1 2026, Asset Utilization Ratio rose 18.28% year-over-year to 0.97; the trailing twelve-month figure through Mar 2026 stood at 0.97 (up 18.28% YoY), and the FY2025 full-year result was 1.0, up 26.43% from the prior year.
  • Asset Utilization Ratio for Q1 2026 stood at 0.97, up from 0.94 in the prior quarter.
  • The five-year high for Asset Utilization Ratio was 0.97 in Q1 2026, with the low at 0.35 in Q1 2022.
  • Average Asset Utilization Ratio over 5 years is 0.66, with a median of 0.67 recorded in 2024.
  • Year-over-year, Asset Utilization Ratio tumbled 56.69% in 2022 and surged 63.27% in 2023.
  • Tracing NPCE's Asset Utilization Ratio over 5 years: stood at 0.39 in 2022, then soared by 62.91% to 0.63 in 2023, then jumped by 32.38% to 0.84 in 2024, then advanced by 12.27% to 0.94 in 2025, then advanced by 3.61% to 0.97 in 2026.
  • The last three Asset Utilization Ratio figures came in at 0.97 (Q1 2026), 0.94 (Q4 2025), and 0.89 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.46
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 0.54
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.39
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.47
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.47
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.65
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 0.74
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.57
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 0.56
10 NeuroPace 558.86 Mn 504.88 Mn 18.05 Mn 0.97

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.97
Dec 31, 2025 0.94
Sep 30, 2025 0.89
Jun 30, 2025 0.82
Mar 31, 2025 0.82
Dec 31, 2024 0.84
Sep 30, 2024 0.80
Jun 30, 2024 0.74
Mar 31, 2024 0.67
Dec 31, 2023 0.63
Sep 30, 2023 0.60
Jun 30, 2023 0.53
Mar 31, 2023 0.44
Dec 31, 2022 0.39
Sep 30, 2022 0.37
Jun 30, 2022 0.35
Mar 31, 2022 0.35
Dec 31, 2021 0.33
Sep 30, 2021 0.31
Jun 30, 2021 0.48
Mar 31, 2021 0.80